Form 4: Eli Lilly Director Juan R. Luciano Acquires Shares Under Directors' Deferral Plan

Director Juan R. Luciano acquired shares of Eli Lilly & Co. under the company's Directors' Deferral Plan, deferring cash compensation into stock units.

Summary

• On January 21, 2025, Juan R. Luciano, a director of Eli Lilly & Co., acquired 19.982 shares of common stock at a price of $742.35 per share.
• The acquisition was made under the Lilly Directors' Deferral Plan, where the director elected to defer cash compensation in lieu of stock units.
• Following the transaction, Luciano directly owns 16,211.283 shares of Eli Lilly & Co.
• The acquired shares will be settled in shares of common stock following Luciano's separation from service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director's share acquisition signals confidence, but it's part of a standard deferral plan.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The Directors' Deferral Plan aligns the interests of directors with those of long-term shareholders.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

Director share acquisitions are common and often viewed positively, indicating confidence in the company's prospects. Deferral plans are used to align director and shareholder interests.

Comparison to Industry Standards

• Director share ownership is a common practice across publicly traded companies, particularly in the pharmaceutical industry.
• Companies like Pfizer (PFE) and Johnson & Johnson (JNJ) also have similar director compensation and share ownership guidelines.
• Director share ownership is often seen as a positive sign, aligning the interests of management with those of shareholders.

Stakeholder Impact

• The share acquisition could have a slightly positive impact on shareholder sentiment.
• The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Director, Share Acquisition, Directors' Deferral Plan, Form 4, Eli Lilly, LLY, Insider Trading